Found 6 matching trials
THE EFFECT OF CYP3A5 GENOTYPE ON THE PHARMACOKINETICS OF MARAVIROC PHASE1 This will be an open-label, parallel group, multiple dose study in approxim...
Show More Location
Pfizer New Haven Clinical Research Unit
Learn More & Join Trial
Study to Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated Human Immunodeficiency Virus (HIV-1) Infected Controllers PHASE1 The primary objective of this study is to evaluate the safety and tolerabil...
Show More Location
Mills Clinical Research
Learn More & Join Trial
Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV PHASE2 The goal of this clinical study is to learn more about the safety and dosin...
Show More Status
Active Not Recruiting
Location
Pediatric Infectious Disease Associates
Learn More & Join Trial
Antiretroviral Localization in Gut-Associated Lymphoid Tissue and Lower Female Genital Tract Tissue of HIV+ Subjects N/A The purpose of this research study is to find out how the drugs Truvada® (t...
Show More Location
University of North Carolina at Chapel Hill
Learn More & Join Trial
Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir PHASE3 The purpose of this study is to compare the safety, tolerability and effica...
Show More Location
Southwest Center for HIV/AIDS
Learn More & Join Trial
Maraviroc on HIV-1 Infected Subjects Who Require Allogeneic Hematopoietic Cell Transplant PHASE1 The goal of this proposal is to determine the effect of maraviroc when it h...
Show More Location
Multiple Locations
Learn More & Join Trial